期刊文献+

母细胞性浆细胞样树突细胞肿瘤临床病理观察 被引量:6

Blastic plasmacytoid dendritic cell neoplasm:a case report and of literature review
下载PDF
导出
摘要 目的研究母细胞性浆细胞样树突细胞肿瘤(BPDCN)的临床病理特点、免疫组化、诊断及鉴别诊断。方法报道1例BPDCN,并复习文献总结其临床病理学、免疫组化特征。结果组织形态学表现为肿瘤细胞弥漫分布,中等大小,细胞质少,核不规则,染色质细,核分裂多见,无坏死。免疫组化:肿瘤细胞CD123、CD56、CD43和S-100(+),少数细胞CD4、CD7和TdT(+),CD2、CD3、CD20、CD21、CD34、CD35、CD68、Pax-5、CD99、CD117和MPO(-)。结论 BPDCN是一种少见的淋巴造血系统高度侵袭性肿瘤,预后差,应注意与其他淋巴造血系统肿瘤相鉴别。 Objective To better define the clinicopathologic features of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Methods A case of BPDCN was observed by gross, morphology, immunohistochemical technique and review of literature. Results Morphologically, the lymph node showed diffuse effacement of architecture. The infiltrate comprised monotonous medium-sized cells with round, irregularly folded and convoluted nuclei, fine ehromatin, and a thin rim of light-staining cytoplasm. Immunohistoehemically, tumor cells were positive for CD123, CD56, CD43, S-100 protein, and CD4, CD7, TdT were weak staining while they were negative for CD2, CD3, CD20, CD21, CD34, CD35, CD68, Pax-5, CD99, CD117 and MPO. Conclusion BPDCN is a rare highly aggressive neoplasm of haematopoietic and lymphoid tissues. The differential diagnosis is necessary from other haematopoietic and lymphoid tumors.
出处 《诊断病理学杂志》 CSCD 2010年第5期346-348,共3页 Chinese Journal of Diagnostic Pathology
关键词 母细胞性 浆细胞样树突细胞 免疫组化 鉴别诊断 Blastic Plasmacytoid dendritic cell Immunohistochemistry Differential diagnosis
  • 相关文献

参考文献13

  • 1Jaffe ES,Harris NL,Stein H,et al.World Health Organization classification of tumours.Pathologic and genetic of tumours of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2001.214-215.
  • 2Chaperot L,Perrot I,Jacob MC,et al.Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts[J].Eur J Immunol,2004,34(2):418-426.
  • 3Charperot L,Bendriss N,Manches O,et al.Identification of a leukemic counterpart of the plasmacytoid dendritic cells[J].Blood,2001,97(10):3210-3217.
  • 4Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumours of heamatopioetics and lymphoid tissues[M].4th ed.Lyon:IARC Press,2008.145-147.
  • 5Adachi M,Maeda K,Takekawa M,et al.High expression of CD56(N182CAM) in a patient with cutaneous CD4-positive lymphoma[J].Am J Hematol,1994,47(4):278-282.
  • 6Jegalian AG,Facchetti F,Jaffe ES.Plasmacytoid dendritic cells:physiologic roles and pathologic states[J].Adv Anat Pathol,2009,16(6):392-404.
  • 7Petrella T,Meijer CJ,Dalac S,et al.TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphoma) and leukemia cutis[J].Am J Clin Pathol,2004,122(2):307-313.
  • 8Marafioti T,Paterson JC,Ballabio E,et al.Novel markers of normal and neoplastic human plasmacytoid dendritic cells[J].Blood,2008,111(7):3778-3792.
  • 9Dzionek A,Inagaki Y,Okawa K,et al.Plasmacytoid dendritic cells:from specific surface markers to specific celluar functions[J].Hum Immunol,2002,63(12):1133-1148.
  • 10Bilbao EA,Chirife AM,Florio D,et al.Hematodermic CD4+ CD56+ neoplasm in childhood[J].Medicina (B Aires),2008,68(2):147-150.

二级参考文献12

  • 1Armitage JO,Weisenburger DD.New approach to classifying non-Hodgkin's lymphomas:clinical features of the major histologic subtypes.Non-Hodgkin's Lymphoma Classification Project[J].J Clin Oncol,1998,16(8):2780-2795.
  • 2Jaffe ES,Harris NL,Stein H,et al.WHO Classification of tumors.Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues[ M ].Lyon:IARC Press,2001:111-117.
  • 3Riopel M,Dickman PS,Link MP,et al.MIC2 analysis in pediatric lymphomas and leukemia[ J].Hum Pathol,1994,25(4):396-399.
  • 4Robertson PB,Neiman RS,Worapongpaiboon S,et al.O13(CD99) positivity in hematologic proliferations correlates with TdT positivity[ J ].Mod Pathol,1997,10 (4):277-282.
  • 5Iravani S,Singleton TP,Ross CW,et al.Precursor B lymphoblastic lymphoma presenting as lytic bone lesions[ J ].Am J Clin Pathol,1999,112(6):836-843.
  • 6Quintanilla-Martinez L,Zukerberg LR,Ferry JA,et al.Extramedullary tumors of lymphoid or myeloid blasts.The role of immunohistology in diagnosis and classification[ J ].Am J Clin Pathol,1995,104(4):431-443.
  • 7Perrone T,Frizzera G,Rosai J.Mediastinal diffuse large-cell lymphoma with sclerosis:a clinicopathologic study of 60 cases[J].Am J Surg Pathol,1986,10(3):176-191.
  • 8Di Como C J,Urist M J,Babayan I,et al.P63 expression profiles in human normal and tumor tissues[ J ].Clin Cancer Res,2002,8(2):494-501.
  • 9Hoelzer D,Gokbuget N,Digel W,et al.Leukemia GMSAAL:outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia[J].Blood,2002,99(12):4379-4385.
  • 10Zinzani PL,Bendandi M,Visani G,et al.Adult lymphoblastic lymphoma:clinical features and prognostic factors in 53 patients[J].Leuk Lymph,1996,23(5-6):577-582.

共引文献6

同被引文献63

  • 1吴灵珍,于倩,蒋谊,彭宏凌.母细胞性浆细胞样树突细胞肿瘤患者的临床特点[J].中国实验血液学杂志,2020,28(1):307-313. 被引量:6
  • 2于明华,蔡文宇,田欣,李梅,郑迎春,陈晟华.母细胞性浆细胞样树突细胞肿瘤1例[J].临床检验杂志(电子版),2013,2(1):312-313. 被引量:1
  • 3Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CIM-positive lymphoma[ J]. Am J Hematol, 1994, 47(4) : 278 -282.
  • 4Swerdlow SH, Campo E, Harris NL. WHO Classification of tumours of haematopoietie and lymphoid tissues [ M ]. 4th ed. Lyon: IARC Press, 2008. 145-147.
  • 5Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications [ J ]. Haematologica, 2010, 95 ( 11 ) :1873 - 1879.
  • 6Yang CS, Wang J, Chang TK. Congenital blastic plasmacytoid dendritic cell neoplasm [ J ]. Pediatr Blood Cancer, 2012, 58 (1) :109 -110.
  • 7Tsagarakis NJ, Kentrou NA, Papadimitriou KA, et al. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group [ J ]. Leuk Res, 2010, 34(4) :438 -446.
  • 8Rauh M J, Rahman F, Good D, et al. Blastic plasmaeytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review [ J ]. Leuk Res, 2012, 36(1) :81 -86. Su.
  • 9zuki R, Nakamura S, Suzumiya J, et al. Blastic natural killer cell lymphoma/leukemia ( CD56-positive blastic tumor ) : prognostication and categorization according to anatomic sites of involvement[ J]. Cancer, 2005, 104(5) : 1022 - 1031.
  • 10Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CIM( + )CD56( + ) malignancies[J]. Blood, 2002, 99 (5) : 1556 - 1563.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部